Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq analysis on organoids derived from metastatic tumor patients

ABSTRACT: RNA-seq analysis on organoids derived from metastatic tumor patients

PROVIDER: PRJNA1103724 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28779972_1.fastq.gz	Fastqsanger.gz
	SRR28779972_2.fastq.gz	Fastqsanger.gz
	SRR28779973_1.fastq.gz	Fastqsanger.gz
	SRR28779973_2.fastq.gz	Fastqsanger.gz
	SRR28779974_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

RNA-seq analysis on organoids derived from metastatic tumor patients

Project description:To evaluate the efficiency of apatinib on vascularized patient-derived tumor organoids (PDTOs)-on-a-chip derived from patients with metastatic tumors, we conducted RNA-seq analysis on organoids derived from patients whom had metastatic tumors. Specifically, we extracted RNA for sequencing from tumor cells of organoids either cultured alone or co-cultured with MVs with or without apatinib treatment

2024-04-27 | GSE264645 | GEO

Modeling Tumor Development and Metastasis using Paired Organoids Derived from Patients with Colorectal Cancer Liver Metastases

Project description:Tumor metastasis accounts for the majority of cancer-related deaths; it is therefore important to develop preclinical models that faithfully recapitulate disease progression. Here, we generated paired organoids derived from primary tumors and matched liver metastases in the same colorectal cancer patients (CRC). Despite the fact that paired organoids exhibit comparable gene expression and cell morphology. organoids from metastatic lesions demonstrate more aggressive phenotypes, tumorigenesis, and metastatic capacity than those from primary lesions. Transcriptional analyses of the paired organoids reveal signature genes and pathways altered during the progression of CRC. including SOX2, altered during the progression of CRC. Further study shows that inducible knockdown of SOX2 attenuated invasion, proliferation, and liver metastasis outgrowth. Taken together, we use patient-derived organoids to model cancer metastasis. Our data propose that SOX2 is not only a critical biomarker for the development and metastasis of CRC, but also a potent target for the disease treatment.

2020-10-05 | GSE148918 | GEO

Patient-derived Organoids Predicts the Clinical Efficiency of Colorectal Liver Metastasis

Project description:Accumulating evidence indicates that patient- derived organoids (PDOs) can predict drug responses in the clinic. Metastasis is the main cause of death in colorectal cancer patients, and the treatment of patients with liver metastasis remains poor. Tumor heterogeneity is the cause of treatment failure. In this study, we aim the investigate the consistency of drug sensitivity for the matched primary and metastatic tumor in patients with liver metastasis.

| 2400343 | ecrin-mdr-crc

Gene expression profiling of tumor organoids of colorectal liver metastases.

Project description:We have performed gene expression profiling of patient-derived tumor organoids (PDOs) and tissue samples of resected liver metastases from patients with metastatic colorectal cancer.

2026-04-20 | GSE294511 | GEO

Whole exome sequencing of head and neck patients-derived tumor organoids and formalin fixed paraffin embedded tumor tissue

Project description:Whole exome sequencing of head and neck patients-derived tumor organoids and formalin fixed paraffin embedded tumor tissue

| PRJNA1151740 | ENA

Whole exome sequencing of head and neck patients-derived tumor organoids and formalin fixed paraffin embedded tumor tissue

Project description:Whole exome sequencing of head and neck patients-derived tumor organoids and formalin fixed paraffin embedded tumor tissue

| PRJNA1151738 | ENA

Integrated Proteomic Analysis of YCC-Derived Organoids

Project description:This dataset contains proteomic and phosphoproteomic profiles generated from YCC-derived organoid models. The study includes paired models established from the same patient-derived materials to investigate molecular differences associated with organoid growth and tumor-related biological features. In addition, a larger set of organoids derived from different cancer patients was included to explore global proteomic clustering patterns and subgroup-specific molecular characteristics.

2026-06-19 | PXD076305 | Pride

Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: a real-world study

Project description:Using patient derived lung cancer organoids to predict clinical response and find theraputic mechanisms

| PXD037076 |

Expression Analysis of Mouse Tumor and Metastatic Pancreatic Ductal Adenocarcinoma Organoids

Project description:Expression Analysis of Mouse Tumor and Metastatic Pancreatic Ductal Adenocarcinoma Organoids

| PRJNA597074 | ENA

Tumor Organoids Improve Mutation Detection of Pancreatic Ductal Adenocarcinoma

Project description:This project investigated whether patient-derived organoids (PDOs) can enhance the accurate identification of somatic mutation and tumor-specific neoantigens in PDAC, which generally present with low tumor cellularity. Surgically resected PDAC tumors and their paired PDOs from 21 patients were examined. Whole-exome sequencing (WES) of tumor tissue, organoids, and peripheral blood mononuclear cells was performed to identify somatic mutations.

2024-11-15 | PRJEB76301 | EVA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data